The Journal of Organic Chemistry
Article
8
8
1
.89 (dd, J = 4.3, 1.8 Hz, 1H), 8.16 (d, J = 2.0 Hz, 1H), 7.99 (dd, J =
mg, 75%) was isolated (hexanes/EtOAc = 6.5:1) as colorless oil.
3f
1
.5, 1.8 Hz, 1H), 7.91 (dd, J = 8.9, 2.0 Hz, 1H), 7.80 (d, J = 8.9 Hz,
Spectroscopic data matched with those reported in the literature.
H
1
3
1
H), 7.37 (dd, J = 8.3, 4.2 Hz, 1H); C{ H} NMR (126 MHz,
NMR (500 MHz, CDCl ): δ 8.92 (d, J = 4.3 Hz, 1H), 8.13 (dd, J =
3
CDCl ): δ 150.8, 147.1, 138.1, 136.4, 134.7, 131.1, 129.8, 121.6, 92.1;
8.5, 1.5 Hz, 1H), 7.86 (dd, J = 8.5, 1.6 Hz, 1H), 7.71 (ddd, J = 8.3,
6.8, 1.4 Hz, 1H), 7.58 (dt, J = 4.4, 1.3 Hz, 1H), 7.54 (ddd, J = 8.3, 6.8,
1.3 Hz, 1H), 5.23 (d, J = 1.4 Hz, 2H), 0.99 (s, 9H), 0.16 (s, 6H);
3
+
GC−MS (EI, 70 eV) m/z: calcd for [M] (C H IN), 255.0; found,
9
6
254.9.
1
3
1
3
-Methylquinoline (3r). Prepared using 3-methylquinoline N-oxide
C{ H} NMR (126 MHz, CDCl ): δ 150.6, 147.7, 146.6, 130.2,
3
(
2r, 31.8 mg, 0.200 mmol, 1.00 equiv), 1c (92.8 mg, 0.300 mmol, 1.50
129.0, 126.3, 125.5, 122.4, 117.7, 61.7, 25.9, 18.4, −5.3; GC−MS (EI,
+
equiv), 4 (1.5 mg, 2.0 μmol, 1.0 mol %), and CH CN (4.00 mL, 0.05
M). 3-Methylquinoline (3r, 26.0 mg, 91%) was isolated (hexanes/
EtOAc = 4:1) as pale yellow oil. Spectroscopic data matched with
those reported in the literature. H NMR (500 MHz, CDCl ): δ
70 eV) m/z: calcd for [M] (C H NOSi), 273.2; found, 273.1.
3
16 23
3-(1,3-Dioxolan-2-yl)quinoline (3x). Prepared using 3-(1,3-dioxo-
lan-2-yl)quinoline N-oxide (2x, 34.6 mg, 0.200 mmol, 1.00 equiv), 1c
(92.8 mg, 0.300 mmol, 1.50 equiv), 4 (1.5 mg, 2.0 μmol, 1.0 mol %),
3f
1
3
8
.76 (d, J = 2.3 Hz, 1H), 8.06 (d, J = 8.5 Hz, 1H), 7.89 (s, 1H), 7.72
and CH CN (4.00 mL, 0.05 M). 3-(1,3-Dioxolan-2-yl)quinoline (3x,
3
(
(
dd, J = 8.2, 1.4 Hz, 1H), 7.63 (ddd, J = 8.5, 6.9, 1.5 Hz, 1H), 7.50
ddd, J = 8.1, 6.8, 1.2 Hz, 1H), 2.50 (s, 3H); C{ H} NMR (126
32.3 mg, 80%) was isolated (hexanes/EtOAc = 1.4:1) as pale yellow
1
3
1
3f
oil. Spectroscopic data matched with those reported in the literature.
1
MHz, CDCl ): δ 152.4, 146.5, 134.6, 130.4, 129.1, 128.4, 128.1,
1
(
H NMR (500 MHz, CDCl ): δ 8.95 (d, J = 2.2 Hz, 1H), 8.13 (d, J =
3
3
+
27.1, 126.5, 18.7; GC−MS (EI, 70 eV) m/z: calcd for [M]
C H N), 143.1; found, 143.2.
2
.2 Hz, 1H), 8.05 (dd, J = 8.5, 1.0 Hz, 1H), 7.72 (dd, J = 8.1, 1.5 Hz,
10
9
1H), 7.62 (ddd, J = 8.5, 6.9, 1.5 Hz, 1H), 7.43 (ddd, J = 8.2, 6.9, 1.2
Hz, 1H), 5.91 (s, 1H), 4.09−3.91 (m, 4H); C{ H} NMR (126
MHz, CDCl ): δ 148.9, 148.2, 133.7, 130.6, 129.6, 129.0, 127.8,
1
3
1
4
-Methylquinoline (3s). Prepared using 4-methylquinoline N-oxide
(
2s, 31.8 mg, 0.200 mmol, 1.00 equiv), 1c (92.8 mg, 0.300 mmol, 1.50
3
+
equiv), 4 (1.5 mg, 2.0 μmol, 1.0 mol %), and CH CN (4.00 mL, 0.05
3
127.1, 126.6, 101.9, 65.2; GC−MS (EI, 70 eV) m/z: calcd for [M]
M). 4-Methylquinoline (3s, 25.6 mg, 90%) was isolated (hexanes/
EtOAc = 4:1) as pale yellow oil. Spectroscopic data matched with
those reported in the literature. H NMR (500 MHz, CDCl ): δ
(C H NO ), 201.1; found, 201.2.
12 11 2
6
-(Phenylethynyl)quinoline (3y). Prepared using 6-
3f
1
3
(phenylethynyl)quinoline N-oxide (2y, 49.1 mg, 0.200 mmol, 1.00
equiv), 1c (92.8 mg, 0.300 mmol, 1.50 equiv), 4 (1.5 mg, 2.0 μmol,
8
8
8
.72 (d, J = 4.3 Hz, 1H), 8.07 (dd, J = 8.5, 1.3 Hz, 1H), 7.91 (dd, J =
.4, 1.5 Hz, 1H), 7.65 (ddd, J = 8.5, 6.8, 1.4 Hz, 1H), 7.49 (ddd, J =
1
.0 mol %), and CH CN (4.00 mL, 0.05 M). 6-(Phenylethynyl)-
3
.3, 6.9, 1.3 Hz, 1H), 7.13 (dd, J = 4.3, 1.1 Hz, 1H), 2.61 (s, 3H);
quinoline (3y, 42.3 mg, 92%) was isolated (hexanes/EtOAc = 1.6:1)
13
1
C{ H} NMR (126 MHz, CDCl ): δ 150.0, 147.8, 144.0, 129.8,
3
as a pale yellow solid. Spectroscopic data matched with those reported
3f
1
1
28.9, 128.1, 126.1, 123.6, 121.7, 18.4; GC−MS (EI, 70 eV) m/z:
in the literature. H NMR (500 MHz, CDCl ): δ 8.89 (dd, J = 4.2,
3
+
calcd for [M] (C H N), 143.1; found, 143.2.
1.8 Hz, 1H), 8.11−8.04 (m, 2H), 7.99 (d, J = 1.8 Hz, 1H), 7.81 (dd, J
10
9
1
3
1
2
,6-Dimethylquinoline (3t). Prepared using 2,6-dimethylquinoline
= 8.8, 1.9 Hz, 1H), 7.61−7.54 (m, 2H), 7.41−7.32 (m, 4H); C{ H}
N-oxide (2t, 34.6 mg, 0.200 mmol, 1.00 equiv), 1c (92.8 mg, 0.300
mmol, 1.50 equiv), 4 (1.5 mg, 2.0 μmol, 1.0 mol %), and CH CN
NMR (126 MHz, CDCl ): δ 150.8, 147.6, 135.6, 132.1, 131.6, 131.0,
3
3
129.5, 128.5, 128.4, 127.9, 122.9, 121.6, 121.5, 90.6, 88.9; GC−MS
+
(
4.00 mL, 0.05 M). 2,6-Dimethylquinoline (3t, 23.9 mg, 76%) was
(EI, 70 eV) m/z: calcd for [M] (C H N), 229.1; found, 229.1.
1
7
11
isolated (hexanes/EtOAc = 2.5:1) as an off-white solid. Spectroscopic
Quinoxaline (3z). Prepared using quinoxaline N-oxide (2z, 29.2
mg, 0.200 mmol, 1.00 equiv), 1c (92.8 mg, 0.300 mmol, 1.50 equiv),
3f
1
data matched with those reported in the literature. H NMR (500
MHz, CDCl ): δ 7.90 (s, 1H), 7.89 (s, 1H), 7.50−7.44 (m, 2H), 7.19
4 (1.5 mg, 2.0 μmol, 1.0 mol %), and CH CN (4.00 mL, 0.05 M).
3
3
1
3
1
(
d, J = 8.3 Hz, 1H), 2.69 (s, 3H), 2.48 (s, 3H); C{ H} NMR (126
Quinoxaline (3z, 20.0 mg, 77%) was isolated (hexanes/EtOAc = 4:1)
MHz, CDCl ): δ 157.8, 146.4, 135.4, 135.2, 131.5, 128.2, 126.4,
as pale yellow oil. Spectroscopic data matched with those reported in
3
+
40a
1
1
(
26.3, 121.8, 25.2, 21.3; GC−MS (EI, 70 eV) m/z: calcd for [M]
C H N), 157.1; found, 157.2.
the literature.
H NMR (500 MHz, CDCl ): δ 8.67 (s, 2H), 7.98−
3
13 1
11
11
7.91 (m, 2H), 7.64−7.54 (m, 2H); C{ H} NMR (126 MHz,
2
-Phenylquinoline (3u). Prepared using 2-phenylquinoline N-
CDCl ): δ 144.6, 142.7, 129.6, 129.2; GC−MS (EI, 70 eV) m/z:
3
+
oxide (2u, 44.3 mg, 0.200 mmol, 1.00 equiv), 1c (92.8 mg, 0.300
mmol, 1.50 equiv), 4 (1.5 mg, 2.0 μmol, 1.0 mol %), and CH CN
calcd for [M] (C H N ), 130.1; found, 130.1.
8
6
2
3
Isoquinoline (3aa). Prepared using isoquinoline N-oxide (2aa, 29.0
mg, 0.200 mmol, 1.00 equiv), 1c (92.8 mg, 0.300 mmol, 1.50 equiv),
(
4.00 mL, 0.05 M). 2-Phenylquinoline (3u, 32.9 mg, 80%) was
isolated (hexanes/EtOAc = 30:1) as pale yellow oil. Spectroscopic
4 (1.5 mg, 2.0 μmol, 1.0 mol %), and CH CN (4.00 mL, 0.05 M).
3
3f
1
data matched with those reported in the literature. H NMR (500
Isoquinoline (3aa, 24.8 mg, 96%) was isolated (hexanes/EtOAc =
MHz, CDCl ): δ 8.25 (d, J = 8.6 Hz, 1H), 8.23−8.17 (m, 3H), 7.91
2.1:1) as dark brown oil. Spectroscopic data matched with those
3
3f
1
(d, J = 8.6 Hz, 1H), 7.86 (dd, J = 8.1, 1.5 Hz, 1H), 7.76 (ddd, J = 8.4,
reported in the literature. H NMR (500 MHz, CDCl ): δ 9.29 (s,
3
1
3
1
6
.8, 1.5 Hz, 1H), 7.61−7.53 (m, 3H), 7.53−7.46 (m, 1H); C{ H}
1H), 8.55 (s, 1H), 7.95 (d, J = 8.2 Hz, 1H), 7.80 (d, J = 8.2 Hz, 1H),
1
3
1
NMR (126 MHz, CDCl ): δ 157.3, 148.3, 139.7, 136.7, 129.8, 129.6,
7.71−7.63 (m, 2H), 7.60 (t, J = 7.3 Hz, 1H); C{ H} NMR (126
3
1
29.3, 128.8, 127.6, 127.4, 127.2, 126.2, 119.0; GC−MS (EI, 70 eV)
MHz, CDCl ): δ 152.4, 142.8, 135.7, 130.3, 128.7, 127.6, 127.2,
3
+
+
m/z: calcd for [M] (C H N), 205.1; found, 205.1.
126.4, 120.5; GC−MS (EI, 70 eV) m/z: calcd for [M] (C H N),
129.1; found, 129.1.
1
5
11
9
7
6
-Methoxyquinoline (3v). Prepared using 6-methoxyquinoline N-
oxide (2v, 35.0 mg, 0.200 mmol, 1.00 equiv), 1c (92.8 mg, 0.300
mmol, 1.50 equiv), 4 (1.5 mg, 2.0 μmol, 1.0 mol %), and CH CN
5-Bromoisoquinoline (3ab). Prepared using 5-bromoisoquinoline
N-oxide (2ab, 44.8 mg, 0.200 mmol, 1.00 equiv), 1c (92.8 mg, 0.300
3
(
4.00 mL, 0.05 M). 6-Methoxyquinoline (3v, 25.3 mg, 80%) was
mmol, 1.50 equiv), 4 (1.5 mg, 2.0 μmol, 1.0 mol %), and CH CN
3
isolated (hexanes/EtOAc = 2:1) as pale yellow oil. Spectroscopic data
(4.00 mL, 0.05 M). 5-Bromoisoquinoline (3ab, 36.2 mg, 87%) was
3f
1
matched with those reported in the literature. H NMR (500 MHz,
CDCl ): δ 8.75 (dd, J = 4.2, 1.7 Hz, 1H), 8.02 (dd, J = 8.4, 2.0 Hz,
isolated (hexanes/EtOAc = 3:1) as a brown solid. Spectroscopic data
3f
1
3
matched with those reported in the literature. H NMR (500 MHz,
1
H), 7.99 (d, J = 9.2 Hz, 1H), 7.36 (dd, J = 9.2, 2.8 Hz, 1H), 7.32
CDCl ): δ 9.18 (s, 1H), 8.60 (d, J = 6.0 Hz, 1H), 7.92−7.86 (m, 3H),
3
1
3
1
(dd, J = 8.3, 4.2 Hz, 1H), 7.04 (d, J = 2.8 Hz, 1H), 3.91 (s, 3H);
7.40 (t, J = 7.8 Hz, 1H); C{ H} NMR (126 MHz, CDCl ): δ 152.6,
3
13
1
C{ H} NMR (126 MHz, CDCl ): δ 157.7, 147.9, 144.4, 134.7,
144.4, 134.8, 133.8, 129.5, 127.6, 127.3, 121.4, 119.2; GC−MS (EI,
3
+
1
30.8, 129.2, 122.2, 121.3, 105.1, 55.5; GC−MS (EI, 70 eV) m/z:
70 eV) m/z: calcd for [M] (C H BrN), 207.0; found, 206.9.
9
6
+
calcd for [M] (C H NO), 159.1; found, 159.1.
Phthalazine (3ac). Prepared using phthalazine N-oxide (2ac, 29.2
mg, 0.200 mmol, 1.00 equiv), 1c (92.8 mg, 0.300 mmol, 1.50 equiv),
10
9
4
-(((tert-Butyldimethylsilyl)oxy)methyl)quinoline (3w). Prepared
using 4-(((tert-butyldimethylsilyl)oxy)methyl)quinoline N-oxide (2w,
8.9 mg, 0.100 mmol, 1.00 equiv), 1c (46.4 mg, 0.150 mmol, 1.50
4 (1.5 mg, 2.0 μmol, 1.0 mol %), and CH CN (4.00 mL, 0.05 M).
3
2
Phthalazine (3ac, 20.1 mg, 77%) was isolated (EtOAc/acetone = 2:1)
equiv), 4 (0.8 mg, 1.0 μmol, 1.0 mol %), and CH CN (2.00 mL, 0.05
M). 4-(((tert-Butyldimethylsilyl)oxy)methyl)quinoline (3w) (20.5
as pale yellow oil. Spectroscopic data matched with those reported in
3
3f
1
the literature. H NMR (500 MHz, CDCl ): δ 9.53 (s, 2H), 7.99−
3
2
888
J. Org. Chem. 2021, 86, 2876−2894